Three Endocrine Society members have taken home the 2024 Lasker~DeBakey Clinical Medical Research Award. Joel F. Habener, MA, MD, chief of Laboratory of Molecular Endocrinology, Massachusetts General Hospital; Lotte Bjerre Knudsen, DMSc, chief scientific advisor and head of the GLP-1 Centre of Excellence at Novo Nordisk; and Svetlana Mojsov, PhD, research associate professor at Rockefeller...
Endocrine Society member Lorenzo Smith, a PhD candidate at the Huntsman Cancer Institute at the University of Utah, has been selected as a Howard Garrison Advocacy Fellow through the Federation of American Societies for Experimental Biology (FASEB). This program is designed to train and support scientists seeking opportunities to learn more about the policymaking process...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Neuroendocrine Tumor Treatment Data Presented by Exelixis On September 16, Exelixis announced updated and final data from CABINET, a Phase 3 pivotal trial evaluating cabozantinib (CABOMETYX®) versus placebo in two cohorts of patients with previously treated neuroendocrine tumors: one cohort with...
Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to...
Consuming moderate amounts of coffee and caffeine regularly may offer a protective effect against developing multiple cardiometabolic diseases, including type 2 diabetes, coronary heart disease, and stroke, according to new research published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Researchers found that regular coffee or caffeine intake, especially at moderate levels, was associated...
The seasons are a-changing, with fall coming to those of us in the northern hemisphere and springtime to our members and friends in the southern hemisphere. It’s a wonderful time of year, as students in the north return to class, and students in the south start to look forward to summer vacation. For many colleagues,...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Study Data Support Efficacy of Treatment for Vasomotor Symptoms Associated with Menopause As reported in the Sept. 6 Pharma Fridays, Bayer will present detailed results from the Phase III study OASIS 3, providing supporting efficacy data and sustained safety data over...
Despite the reasons for pursuing medicine as a career, there will always be speed bumps that can lead to frustration, stress, burnout, or even a career or job change. Michael Morkos, MD, offers some tips on navigating the challenging and often confusing world of medical billing. Many of us decided to pursue medicine for a...
The seasons are a-changing, with fall coming to those of us in the northern hemisphere and springtime to our members and friends in the southern hemisphere. It’s a wonderful time of year, as students in the north return to class, and students in the south start to look forward to summer vacation. For many colleagues,...
Despite the reasons for pursuing medicine as a career, there will always be speed bumps that can lead to frustration, stress, burnout, or even a career or job change. Michael Morkos, MD, offers some tips on navigating the challenging and often confusing world of medical billing. Many of us decided to pursue medicine for a...
